Published in J Exp Med on August 18, 2003
T cell-independent and toll-like receptor-dependent antigen-driven activation of autoreactive B cells. Immunity (2008) 2.03
Murine visceral leishmaniasis: IgM and polyclonal B-cell activation lead to disease exacerbation. Eur J Immunol (2010) 1.11
New concepts of complement in allorecognition and graft rejection. Cell Immunol (2007) 1.02
B cell acquisition of antigen in vivo. Curr Opin Immunol (2009) 0.92
The classical complement pathway in transplantation: unanticipated protective effects of C1q and role in inductive antibody therapy. Am J Transplant (2008) 0.92
Requirement for complement in antibody responses is not explained by the classic pathway activator IgM. Proc Natl Acad Sci U S A (2011) 0.90
Uncoupling CD21 and CD19 of the B-cell coreceptor. Proc Natl Acad Sci U S A (2009) 0.82
Defective B cell ontogeny and immune response in human complement receptor 2 (CR2, CD21) transgenic mice is partially recovered in the absence of C3. Mol Immunol (2007) 0.77
Dengue Virus Directly Stimulates Polyclonal B Cell Activation. PLoS One (2015) 0.76
Signal transduction by lymphocyte antigen receptors. Cell (1994) 10.63
Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet (1998) 8.20
In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. I. The architecture and dynamics of responding cell populations. J Exp Med (1991) 4.98
Two different complement receptors on human lymphocytes. One specific for C3b and one specific for C3b inactivator-cleaved C3b. J Exp Med (1973) 4.46
A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J Exp Med (1999) 3.74
The follicular dendritic cell: its role in antigen presentation in the generation of immunological memory. Immunol Rev (1980) 3.53
In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. II. A common clonal origin for periarteriolar lymphoid sheath-associated foci and germinal centers. J Exp Med (1992) 3.13
Role of complement in induction of the allergic response. Nat New Biol (1972) 2.90
CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science (1992) 2.79
Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc Natl Acad Sci U S A (1996) 2.71
Activation of mouse complement by different classes of mouse antibody. Immunology (1979) 2.68
The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity. Annu Rev Immunol (1995) 2.64
Enhanced B-1 cell development, but impaired IgG antibody responses in mice deficient in secreted IgM. J Immunol (1998) 2.52
Regulation of the B cell response to T-dependent antigens by classical pathway complement. J Immunol (1996) 2.51
Human lymphocytes bear membrane receptors for C3b and C3d. J Clin Invest (1973) 2.46
Abrogation of the alternative complement pathway by targeted deletion of murine factor B. Proc Natl Acad Sci U S A (1997) 2.44
A role for lipid rafts in B cell antigen receptor signaling and antigen targeting. J Exp Med (1999) 2.42
Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. Immunity (1996) 2.29
The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules. J Immunol (1992) 2.17
Germinal center initiation, variable gene region hypermutation, and mutant B cell selection without detectable immune complexes on follicular dendritic cells. J Exp Med (2000) 2.03
The immune complex: possible ways of regulating the antibody response. Immunol Today (1990) 1.96
A rheumatoid factor transgenic mouse model of autoantibody regulation. Int Immunol (1993) 1.95
Targeted gene disruption reveals a role for natural secretory IgM in the maturation of the primary immune response. Proc Natl Acad Sci U S A (1998) 1.94
Lipid rafts unite signaling cascades with clathrin to regulate BCR internalization. Immunity (2002) 1.86
Lipid rafts and B-cell activation. Nat Rev Immunol (2002) 1.68
Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytes. J Immunol (1988) 1.62
The generation of memory cells. II. Generation of B memory cells with preformed antigen-antibody complexes. Immunology (1978) 1.60
Dependence of germinal center B cells on expression of CD21/CD35 for survival. Science (1998) 1.59
The CD19/CD21 signal transduction complex of B lymphocytes. Immunol Today (1994) 1.57
Antibody response to a T-dependent antigen requires B cell expression of complement receptors. J Exp Med (1996) 1.52
Epstein-Barr virus coopts lipid rafts to block the signaling and antigen transport functions of the BCR. Immunity (2001) 1.47
Generation of memory cells. III. Antibody class requirements for the generation of B-memory cells by antigen--antibody complexes. Immunology (1979) 1.43
Natural antibody and complement-mediated antigen processing and presentation by B lymphocytes. J Immunol (1994) 1.30
The CD19 complex of B lymphocytes. Activation of phospholipase C by a protein tyrosine kinase-dependent pathway that can be enhanced by the membrane IgM complex. J Immunol (1991) 1.17
Reconstitution of the complement function in C1q-deficient (C1qa-/-) mice with wild-type bone marrow cells. J Immunol (2001) 1.14
Humoral immune responses in Cr2-/- mice: enhanced affinity maturation but impaired antibody persistence. J Immunol (2000) 1.14
Translocation of the B cell antigen receptor into lipid rafts reveals a novel step in signaling. J Immunol (2001) 1.14
The CD19/CD21 complex functions to prolong B cell antigen receptor signaling from lipid rafts. Immunity (2001) 1.11
Antigen-induced murine B cell lymphomas. I. Induction and characterization of CH1 and CH2. J Immunol (1978) 1.11
Complement activation is required for IgM-mediated enhancement of the antibody response. J Exp Med (1988) 1.08
CR2 is the primary acceptor site for C3 during alternative pathway activation of complement on human peripheral B lymphocytes. J Immunol (1994) 1.07
T cell-dependent immune response in C1q-deficient mice: defective interferon gamma production by antigen-specific T cells. J Exp Med (1998) 1.05
Rafts and synapses in the spatial organization of immune cell signaling receptors. J Leukoc Biol (2001) 1.02
Complement's participation in acquired immunity. J Leukoc Biol (2002) 0.96
Influence of genetically inherited complement deficiencies on humoral immune response in guinea pigs. J Immunol (1985) 0.93
C1 binding by murine IgM. The effect of a Pro-to-Ser exchange at residue 436 of the mu-chain. J Biol Chem (1988) 0.88
The requirement of localized, CR2-mediated, alternative pathway activation of complement for covalent deposition of C3 fragments on normal B cells. Immunology (1998) 0.87
CR2-mediated activation of the complement alternative pathway results in formation of membrane attack complexes on human B lymphocytes. Immunology (2001) 0.85
Antibody production in mice deficient for complement receptors 1 and 2 can be induced by IgG/Ag and IgE/Ag, but not IgM/Ag complexes. J Immunol (2000) 0.84
The role of complement receptors type 1 (CR1, CD35) and 2 (CR2, CD21) in promoting C3 fragment deposition and membrane attack complex formation on normal peripheral human B cells. Eur J Immunol (2002) 0.84
Mapping of amino acid residues in the C mu 3 domain of mouse IgM important in macromolecular assembly and complement-dependent cytolysis. J Immunol (1994) 0.84
The structural basis for complement receptor type 2 (CR2, CD21)-mediated alternative pathway activation of complement: studies with CR2 deletion mutants and vaccinia virus complement-control protein-CR2 chimeras. Eur J Immunol (1999) 0.77
Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature (2002) 11.05
Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity (2006) 6.00
RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement. J Exp Med (2005) 4.85
Evolution of autoantibody responses via somatic hypermutation outside of germinal centers. Science (2002) 4.21
Epidermal langerhans cell-deficient mice develop enhanced contact hypersensitivity. Immunity (2005) 4.06
PD-1 regulates germinal center B cell survival and the formation and affinity of long-lived plasma cells. Nat Immunol (2010) 3.51
Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus. J Exp Med (2005) 3.43
Activation of autoreactive B cells by CpG dsDNA. Immunity (2003) 3.40
Definition of germinal-center B cell migration in vivo reveals predominant intrazonal circulation patterns. Immunity (2007) 3.07
B cell receptor signal transduction in the GC is short-circuited by high phosphatase activity. Science (2012) 3.03
Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice. J Clin Invest (2007) 2.81
New markers for murine memory B cells that define mutated and unmutated subsets. J Exp Med (2007) 2.65
Memory CD4+ T cells do not induce graft-versus-host disease. J Clin Invest (2003) 2.54
Langerhans cells are not required for efficient skin graft rejection. J Invest Dermatol (2008) 2.41
Donor B-cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bronchiolitis obliterans. Blood (2011) 2.33
Depletion of B cells in murine lupus: efficacy and resistance. J Immunol (2007) 2.25
Type II (tositumomab) anti-CD20 monoclonal antibody out performs type I (rituximab-like) reagents in B-cell depletion regardless of complement activation. Blood (2008) 2.22
TLR9 regulates TLR7- and MyD88-dependent autoantibody production and disease in a murine model of lupus. J Immunol (2010) 2.09
Very low affinity B cells form germinal centers, become memory B cells, and participate in secondary immune responses when higher affinity competition is reduced. J Exp Med (2002) 2.07
T cell-independent and toll-like receptor-dependent antigen-driven activation of autoreactive B cells. Immunity (2008) 2.03
Autocrine/paracrine TGFbeta1 is required for the development of epidermal Langerhans cells. J Exp Med (2007) 2.00
Anti-chromatin antibodies drive in vivo antigen-specific activation and somatic hypermutation of rheumatoid factor B cells at extrafollicular sites. Eur J Immunol (2007) 2.00
NADPH oxidase inhibits the pathogenesis of systemic lupus erythematosus. Sci Transl Med (2012) 1.99
MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies. J Exp Med (2013) 1.88
BLyS inhibition eliminates primary B cells but leaves natural and acquired humoral immunity intact. Proc Natl Acad Sci U S A (2008) 1.88
Attenuated liver fibrosis in the absence of B cells. J Clin Invest (2005) 1.82
Cutting edge: Hierarchy of maturity of murine memory B cell subsets. J Immunol (2010) 1.82
Recipient CD4+ T cells that survive irradiation regulate chronic graft-versus-host disease. Blood (2004) 1.82
Investigation of the role of B-cells in type 1 diabetes in the NOD mouse. Diabetes (2004) 1.76
Maintenance of the plasma cell pool is independent of memory B cells. Proc Natl Acad Sci U S A (2008) 1.75
Antigen-specific B cells are required as APCs and autoantibody-producing cells for induction of severe autoimmune arthritis. J Immunol (2005) 1.74
Dendritic cells in lupus are not required for activation of T and B cells but promote their expansion, resulting in tissue damage. Immunity (2010) 1.70
Regulation of lupus-related autoantibody production and clinical disease by Toll-like receptors. Semin Immunol (2007) 1.69
Hepatocyte mitochondrial DNA drives nonalcoholic steatohepatitis by activation of TLR9. J Clin Invest (2016) 1.62
Antigen-specific B-1a antibodies induced by Francisella tularensis LPS provide long-term protection against F. tularensis LVS challenge. Proc Natl Acad Sci U S A (2009) 1.61
A repertoire-independent and cell-intrinsic defect in murine GVHD induction by effector memory T cells. Blood (2011) 1.60
Requirement of B cells for generating CD4+ T cell memory. J Immunol (2009) 1.60
Langerhans cells suppress contact hypersensitivity responses via cognate CD4 interaction and langerhans cell-derived IL-10. J Immunol (2009) 1.60
Target antigens determine graft-versus-host disease phenotype. J Immunol (2004) 1.57
Plasticity and heterogeneity in the generation of memory B cells and long-lived plasma cells: the influence of germinal center interactions and dynamics. J Immunol (2010) 1.51
Improved methods for detecting selection by mutation analysis of Ig V region sequences. Int Immunol (2008) 1.50
Enhancing alloreactivity does not restore GVHD induction but augments skin graft rejection by CD4⁺ effector memory T cells. Eur J Immunol (2011) 1.49
Taking advantage: high-affinity B cells in the germinal center have lower death rates, but similar rates of division, compared to low-affinity cells. J Immunol (2009) 1.49
Mechanisms of central nervous system viral persistence: the critical role of antibody and B cells. J Immunol (2002) 1.48
B cells drive early T cell autoimmunity in vivo prior to dendritic cell-mediated autoantigen presentation. J Immunol (2006) 1.44
Murine B cell response to TLR7 ligands depends on an IFN-beta feedback loop. J Immunol (2009) 1.42
Signals via the adaptor MyD88 in B cells and DCs make distinct and synergistic contributions to immune activation and tissue damage in lupus. Immunity (2013) 1.40
Autoreactive B cells discriminate CpG-rich and CpG-poor DNA and this response is modulated by IFN-alpha. J Immunol (2008) 1.39
Systematic comparison of gene expression between murine memory and naive B cells demonstrates that memory B cells have unique signaling capabilities. J Immunol (2008) 1.37
Detecting selection in immunoglobulin sequences. Nucleic Acids Res (2011) 1.35
Short-lived plasmablasts dominate the early spontaneous rheumatoid factor response: differentiation pathways, hypermutating cell types, and affinity maturation outside the germinal center. J Immunol (2005) 1.35
Estimating hypermutation rates from clonal tree data. J Immunol (2003) 1.34
In vivo imaging studies shed light on germinal-centre development. Nat Rev Immunol (2007) 1.32
Effects of donor T-cell trafficking and priming site on graft-versus-host disease induction by naive and memory phenotype CD4 T cells. Blood (2008) 1.27
Reassessing the function of immune-complex retention by follicular dendritic cells. Nat Rev Immunol (2003) 1.27
B cell-derived IL-10 does not regulate spontaneous systemic autoimmunity in MRL.Fas(lpr) mice. J Immunol (2011) 1.12
Histone modifications associated with somatic hypermutation. Immunity (2005) 1.10
Memory B cell survival and function in the absence of secreted antibody and immune complexes on follicular dendritic cells. J Immunol (2006) 1.10
Expression of diabetes-associated genes by dendritic cells and CD4 T cells drives the loss of tolerance in nonobese diabetic mice. J Immunol (2009) 1.10
TLR9 promotes tolerance by restricting survival of anergic anti-DNA B cells, yet is also required for their activation. J Immunol (2013) 1.07
Cutting edge: B cells are essential for protective immunity against Salmonella independent of antibody secretion. J Immunol (2012) 1.05
Intrinsic properties of human and murine memory B cells. Immunol Rev (2006) 1.05
Rheumatoid factor B cell memory leads to rapid, switched antibody-forming cell responses. J Immunol (2013) 1.03
CD80 expression on B cells regulates murine T follicular helper development, germinal center B cell survival, and plasma cell generation. J Immunol (2012) 1.02
Langerhans cells are not required for graft-versus-host disease. Blood (2010) 1.01
A new site-directed transgenic rheumatoid factor mouse model demonstrates extrafollicular class switch and plasmablast formation. Autoimmunity (2010) 1.01
Exacerbated autoimmunity in the absence of TLR9 in MRL.Fas(lpr) mice depends on Ifnar1. J Immunol (2013) 0.99
Context-specific BAFF-R signaling by the NF-κB and PI3K pathways. Cell Rep (2013) 0.99
Visualizing the onset and evolution of an autoantibody response in systemic autoimmunity. J Immunol (2005) 0.98
Differential cytokine production and bystander activation of autoreactive B cells in response to CpG-A and CpG-B oligonucleotides. J Immunol (2009) 0.98
Differences in potential for amino acid change after mutation reveals distinct strategies for kappa and lambda light-chain variation. Proc Natl Acad Sci U S A (2006) 0.97
Single round of antigen receptor signaling programs naive B cells to receive T cell help. Immunity (2010) 0.97
B cell tolerance checkpoints that restrict pathways of antigen-driven differentiation. J Immunol (2006) 0.97
Facultative role for T cells in extrafollicular Toll-like receptor-dependent autoreactive B-cell responses in vivo. Proc Natl Acad Sci U S A (2011) 0.96
IRF4 controls the positioning of mature B cells in the lymphoid microenvironments by regulating NOTCH2 expression and activity. J Exp Med (2013) 0.95
Langerhans cell deficiency impairs Ixodes scapularis suppression of Th1 responses in mice. Infect Immun (2009) 0.95
Integrating B cell lineage information into statistical tests for detecting selection in Ig sequences. J Immunol (2013) 0.93
Antigen presentation and transfer between B cells and macrophages. Eur J Immunol (2007) 0.93
The role of innate immunity in autoimmunity. J Exp Med (2004) 0.89
Recipient B cells are not required for graft-versus-host disease induction. Biol Blood Marrow Transplant (2010) 0.88
An acquired defect in IgG-dependent phagocytosis explains the impairment in antibody-mediated cellular depletion in Lupus. J Immunol (2011) 0.88
Multiple transcription factor binding sites predict AID targeting in non-Ig genes. J Immunol (2013) 0.86
Antibody-independent B cell-intrinsic and -extrinsic roles for CD21/35. Eur J Immunol (2006) 0.86
Spontaneous loss of tolerance of autoreactive B cells in Act1-deficient rheumatoid factor transgenic mice. J Immunol (2013) 0.84
Memory T cells in GVHD and GVL. Biol Blood Marrow Transplant (2008) 0.82
Rheumatoid factors in health and disease: structure, function, induction and regulation. Curr Dir Autoimmun (2003) 0.76
B cells and dendritic cells from V kappa 8 light chain transgenic mice activate MRL-lpr/gld CD4+ T cells. J Immunol (2006) 0.76
Recipient gammadelta T cells in graft-versus-host disease. Blood (2006) 0.75
Autoimmunity: The genes and phenotypes of autoimmunity. Curr Opin Immunol (2004) 0.75
Lupus and proliferative nephritis are PAD4 independent in murine models. JCI Insight (2017) 0.75